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BACKGROUND   
Pharmacist-administered vaccination is a reality in many counties including USA, Canada, UK, 
Portugal, Ireland and New Zealand.  In Australia the role of pharmacist administered vaccination has 
long been supported by the profession particularly the Pharmaceutical Society of Australia and 
Pharmacy Guild of Australia, however legislation prohibits this practice in each state and territory. In 
2013 the only available in-pharmacy vaccination services are those delivered by an immunization 
nurse, nurse practitioner or general practitioner.  
 
METHOD 
Using a nurse practitioner and immunisation nurse model, pharmacies across the Terry White 
Chemist group participated in an influenza vaccination program during April and May 2013. Each 
pharmacy was allocated at least one 3 hour session with allowances for multiple sessions depending 
on nurse availability, pharmacy preparedness and projected patient demand. Patients were asked to 
evaluate the service during the 15 minute observation period after vaccination.  
 
RESULTS 
16574 patients were vaccinated over 226 sessions in 150 Terry White Chemists pharmacies. 
Evaluation surveys were completed by 2690 patients. 78% of respondents indicated they will return 
next “flu” season and 90% indicated they would be comfortable with pharmacist-administered 
vaccination 
 
DISCUSSION 
The results suggest not only are patients comfortable with receiving vaccinations in the community 
pharmacy setting, the vast majority surveyed would feel comfortable with vaccinations being 
pharmacist-administered. The addition of immunisation as a pharmacist-led professional service 
should be investigated in the Australian setting.  
